Vascular Effects of Alirocumab in Acute MI-Patients

NCT03067844 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

OTHER

Sponsor class

Conditions

Coronary Vessel
Coronary Circulation
Atheroma; Myocardial

Interventions

DRUG: Alirocumab

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]